Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Clinical features of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) and their repercussions on health-related quality of life (HRQoL) have not been widely studied in Hispanic populations.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Carrillo D
Authors: Carrillo D, Munoz-Anguita G, Madison A, Retamal I, Pinto M,
Keywords: Neuroendocrine, Carcinoid, Health-related quality of life.,
Introduction: Neuroendocrine tumors (NETs) are highly heterogeneous, serum chromogranin A (CgA) has a 60-100% of sensitivity and 68-100% of specificity with a cutoff value of 108 ng/mL as a marker for diagnosis of NETs.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Munoz Medel M
Authors: Munoz-Medel M, Cordova Delgado M, Pinto M, Bravo M, Retamal I,
Keywords: Neuroendocrine, Chromogranin A, Biomarker,
#2103 Neuroendocrine Tumors in the Chilean Population
Introduction: In recent years, neuroendocrine tumors (NETs) have shown a significant raise in prevalence and incidence. However this observation needs to be accurately quantified using reliable epidemiological databases.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Carrillo D
Authors: Carrillo D, Valenzuela Y, Pinto M, Retamal I, Balmaceda C,
Keywords: Neuroendocrine, Carcinoid, Registry, 5-Hydroxyindoleacetic acid, Serotonin, Chromogranin A,
Introduction: Somatostatin analogues (SSA) such as Octreotide and Lanreotide have demonstrated a significant benefit in Neuroendocrine Tumors, particularly in the well/moderately differentiated types. Nevertheless, there are still several aspects of SSA treatments that remain unsolved, such as drug exposition in patients and schedule optimization.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Casanovas O
Authors: Martínez-López A, Pinto J, Lachamp L, Cabello F, Cherif-Cheikh R,
Keywords: Somatostatin Analogs, Octreotide, pNETs, dose scheduling.,
Introduction: CLARINET trial has proven the antiproliferative effects of LAN in patients with non-functioning gastro-entero-pNETs. However, the combination of LAN with targeted therapies is widely used in clinical practice and should be further evaluated.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Casanovas O
Authors: Martínez-López A, Pinto J, Teulé A, Salazar R, Culler M,
Keywords: Lanreotide, pNET,